Cargando…
Tremor in multiple sclerosis
Tremor is estimated to occur in about 25 to 60 percent of patients with multiple sclerosis (MS). This symptom, which can be severely disabling and embarrassing for patients, is difficult to manage. Isoniazid in high doses, carbamazepine, propranolol and gluthetimide have been reported to provide som...
Autores principales: | Koch, Marcus, Mostert, Jop, Heersema, Dorothea, De Keyser, Jacques |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Steinkopff-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915650/ https://www.ncbi.nlm.nih.gov/pubmed/17318714 http://dx.doi.org/10.1007/s00415-006-0296-7 |
Ejemplares similares
-
The Effect of Fluoxetine on Progression in Progressive Multiple Sclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Mostert, Jop, et al.
Publicado: (2013) -
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
por: Cambron, Melissa, et al.
Publicado: (2014) -
MRI brain volume loss, lesion burden, and clinical outcome in
secondary progressive multiple sclerosis
por: Koch, Marcus W, et al.
Publicado: (2021) -
COVID-19 in multiple sclerosis: The Dutch experience
por: Loonstra, Floor C, et al.
Publicado: (2020) -
Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)